| |
| |
|
| Insider
Information: |
Posner Christopher |
| Relationship: |
|
| City: |
Stamford |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
180,521 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$136,384 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
180,521 |
|
|
| Total
Value |
$136,384 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -17.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cara Therapeutics, Inc. |
CARA |
|
2024-02-29 |
180,521 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CARA |
Cara Therapeutics, Inc. |
PRESIDENT AND CEO |
• • – |
2024-02-29 |
4 |
AS |
$0.89 |
$5,192 |
D/D |
(5,834) |
180,521 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
PRESIDENT AND CEO |
• • – |
2024-02-08 |
4 |
AS |
$0.53 |
$18,855 |
D/D |
(35,575) |
186,355 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
PRESIDENT AND CEO |
• • – |
2024-02-01 |
4 |
AS |
$0.55 |
$2,740 |
D/D |
(4,981) |
221,930 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
PRESIDENT AND CEO |
• • – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
226,911 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
President and CEO |
• • – |
2023-08-03 |
4 |
AS |
$3.07 |
$13,222 |
D/D |
(4,307) |
168,207 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
President and CEO |
• • – |
2023-05-05 |
4 |
AS |
$4.40 |
$17,024 |
D/D |
(3,869) |
172,514 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
President and CEO |
• • – |
2023-03-03 |
4 |
AS |
$9.71 |
$58,134 |
D/D |
(5,987) |
176,383 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
President and CEO |
• • – |
2023-02-02 |
4 |
AS |
$11.80 |
$49,454 |
D/D |
(4,191) |
182,370 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
President and CEO |
• • – |
2022-11-16 |
4 |
AS |
$11.13 |
$161,051 |
D/D |
(14,470) |
186,561 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
President and CEO |
• • – |
2022-04-04 |
4 |
AS |
$12.67 |
$25,416 |
D/D |
(2,006) |
201,031 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
President and CEO |
• • – |
2022-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
39,000 |
203,037 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Senior Advisor |
– • – |
2021-10-29 |
4 |
A |
$0.00 |
$0 |
D/D |
147,941 |
164,037 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2021-06-07 |
4 |
AS |
$13.04 |
$30,044 |
D/D |
(2,304) |
16,096 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2021-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,200 |
18,400 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-11-19 |
4 |
S |
$15.82 |
$31,638 |
D/D |
(2,000) |
11,200 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
7,200 |
13,200 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2019-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
